KHRNF - Khiron Life Sciences Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
3.0907
+0.1418 (+4.81%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.9490
Open3.1000
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range2.9990 - 3.2800
52 Week Range0.6637 - 3.2800
Volume955,729
Avg. Volume346,817
Market Cap236.002M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.30200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga9 days ago

    Bulls And Bud Of The Week: Dixie Brands And James Henry

    Broader market action added further downward pressure to cannabis stocks last week, despite a fair amount of good news. Particularly in the edibles space, where Dixie Brands (OTC: DXBRF) announced it entered into a joint venture with Choice Labs, which currently operates two retail locations in Michigan. With this JV in place, Dixie will now be able to bring its products to the Michigan cannabis market, which currently boasts the country’s second-largest patient base.

  • GlobeNewswire15 days ago

    Branding Becomes Key as CBD is Expected to Overtake the Cannabis Market

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot reporting on the CBD market As it grows, branding becomes essential to companies hoping to stand out. According to Brightfield Group analysts, the CBD market is expected to hit $22 billion by 2022, overtaking the cannabis market with $20 billion by 2020. This is good news for most companies in the sector, but it also adds to market saturation, which means brand awareness may be the only way to stay ahead of the pack.

  • Benzinga15 days ago

    Colombia Authorizes First Cannabis Export To Canada: 'This Event Has Been Two Years In The Making'

    In one of the most anticipated moves in the international cannabis space, Colombia is set to begin exporting cannabis to Canada. The first Colombian company to receive approval — from both Health Canada and the Colombian National Narcotics Fund — to export cannabis to Canada is Ecomedics S.A.S., doing business as Clever Leaves. Benzinga had the chance to discuss the move with Andres Fajardo, CEO of Clever Leaves.

  • CNW Group16 days ago

    Khiron Life Sciences announces upsize of previously announced bought deal equity financing to $25 million

    VANCOUVER , Feb. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, and including Cormark Securities Inc. (together, the "Underwriters"), to increase the size of its previously announced "bought deal" financing from $20,020,000 to $25,080,000 (the "Offering"). Pursuant to the amended terms, the Underwriters have agreed to purchase 11,400,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.20 (the "Issue Price").

  • CNW Group17 days ago

    Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing

    VANCOUVER , Feb. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, and including Cormark Securities Inc. (together, the "Underwriters") under which the Underwriters have agreed to purchase 9,100,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.20 (the "Issue Price") for gross proceeds of $20,020,000 (the "Offering"). The Company has also granted the Underwriters an over-allotment option (the "Over-Allotment Option") to purchase up to an additional 15% of the Common Shares at the Issue Price, exercisable in whole or in part at any time on or up to 30 days following the closing of the Offering.

  • ACCESSWIRE18 days ago

    These 4 Marijuana Stocks are Gaining Speed

    CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / The marijuana stock market has continued to demonstrate its strength despite the fact that, at times, conversation surrounding cannabis can become less than beneficial. The cannabis industry as a whole is scheduled to be worth as much as $31 billion by the year 2022, which means that there is a large amount of room left still to grow. Nabis Holdings (INNPF) (NAB), Green Growth Brands Inc (GGBXF) (GGB.CN), Khiron Life Sciences Corp (KHRNF), and The Supreme Cannabis Company Inc (SPRWF) are four cannabis companies working towards improving the quality of life for their consumers.

  • PR Newswire19 days ago

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Feb. 4, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

  • CNW Group23 days ago

    Reminder: Dixie Brands and Khiron Life Sciences to Host Investor Call

    Reminder: Dixie Brands and Khiron Life Sciences to Host Investor Call

  • ACCESSWIRE23 days ago

    4 Marijuana Stocks Seeing New Highs On Wednesday (1/30/19)

    CORAL GABLES, FL / ACCESSWIRE / January 30, 2019 / The 2018 year for the marijuana stock market was instrumental in surmounting much its stability throughout the market, whereas other industries suffered ...

  • Transformative Joint Venture Between Dixie Brands and Khiron Life Sciences Brings a Portfolio of Highly Recognized Cannabis-Infused Products to Latin America and Khiron's Kuida® Cosmeceutical Brand to the Federally legal U.S. CBD Cosmetic Market
    CNW Group24 days ago

    Transformative Joint Venture Between Dixie Brands and Khiron Life Sciences Brings a Portfolio of Highly Recognized Cannabis-Infused Products to Latin America and Khiron's Kuida® Cosmeceutical Brand to the Federally legal U.S. CBD Cosmetic Market

    Transformative Joint Venture Between Dixie Brands and Khiron Life Sciences Brings a Portfolio of Highly Recognized Cannabis-Infused Products to Latin America and Khiron's Kuida® Cosmeceutical Brand to ...

  • PR Newswire24 days ago

    /C O R R E C T I O N -- VirtualInvestorConferences.com/

    In the news release, Khiron Life Sciences to Webcast Live at VirtualInvestorConferences.com on January 30th, issued 28-Jan-2019 by VirtualInvestorConferences.com over PR Newswire, we are advised by the company that the presentation time below the first paragraph was incorrect and should read "10am EST" rather than "9:30am EST" as originally issued inadvertently. TORONTO, Jan. 28, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that Khiron president Chris Naprawa will present live at VirtualInvestorConferences.com on January 30th, where he will discuss recent Company activity and the Latin American cannabis market.

  • PR Newswire25 days ago

    Khiron Life Sciences to Webcast Live at VirtualInvestorConferences.com on January 30th

    TORONTO, Jan. 28, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that Khiron president Chris Naprawa will present live at VirtualInvestorConferences.com on January 30th, where he will discuss recent Company activity and the Latin American cannabis market. This will be a live, interactive online event where investors are invited to ask Company executives questions in real-time - both in the presentation hall as well as the organization's  virtual trade booth.

  • CNW Group29 days ago

    Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the Brazilian Market

    TORONTO , Jan. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Latin America , announced today that the Company has entered into a binding letter agreement dated January 24, 2019 to acquire 100% of NettaGrowth International Inc. ("NettaGro"), an arm's length party, which will own, at the time of completion of the transaction, all the outstanding shares of Dormul S.A. (doing business as Cannapur). Dormul has obtained the first licence to produce medical cannabis with THC for commercialization in Uruguay .

  • PR Newswire29 days ago

    Live Investor Conference & Webinar: Cannabis Industry Companies Present January 30

    Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Jan. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...

  • CNW Grouplast month

    Khiron Life Sciences Expands to Second Latin America Cultivation Jurisdiction on Closing of Agreement with Dayacann to Enter Chilean Medical Cannabis Market

    TORONTO , Jan. 21, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has closed the previously announced MOU with Dayacann, holder of Chile's first medical cannabis cultivation license. As the dominant medical cannabis company in Latin America , this agreement expands on Khiron's multi jurisdiction cultivation strategy, securing access to cannabis cultivation for the Company's use in Chile , participation in clinical trials, and access to commercialize products to meet the needs of a market of 1.8 Million patients across the country.

  • CNW Grouplast month

    Khiron Life Sciences Launches Latin American Medical Education Program With Events in Colombia and Mexico

    TORONTO , Jan. 18, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has launched its Latin America medical education program with a schedule of doctor training and learning events in Bogota, Colombia on January 21-23 , and in Mexico City, Mexico on February 28 .

  • CNW Grouplast month

    Khiron Life Sciences Announced as Co-Host of Cannamexico World Summit 2019

    TORONTO , Jan. 17, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company will co-host Cannamexico World Summit 2019, a comprehensive cannabis symposium taking place April 25 - 26 at Centro Fox , Guanajuato, Mexico . This is the second annual Cannamexico event and is recognized as the first of its kind cannabis summit in Mexico .

  • CNW Grouplast month

    Khiron Life Sciences to Present as Lead Sponsor in First CannaTech Panama Global Medical Cannabis Summit

    TORONTO , Jan. 11, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company will be title sponsor of the first Cannatech Panama summit taking place February 12-13 in Panama City, Panama . Khiron will be prominently featured throughout the summit and key members of the Company's senior medical and compliance team will deliver session presentations on global medical cannabis patient, research and compliance topics with particular impact in Latin America .

  • CNW Group2 months ago

    Khiron Life Sciences Added to Horizons Marijuana Life Sciences Index ETF

    TORONTO , Dec. 31, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that the Company has been added to the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX"), marking the Company's elevation to the senior index of publicly traded North American companies with significant business activity in the cannabis industry.

  • GlobeNewswire2 months ago

    Uptick Newswire Hosts Khiron Life Sciences Corp.’s President to Discuss the Growing Latin American Cannabis Market and How They Have Positioned Themselves as a Leader

    “Khiron is positioned to be the dominant integrated medical cannabis company in Latin America,” Naprawa said as he started the interview. Naprawa went on to say they’ve been at this for two years and have assembled an elite group of people and have a $75 million market share cap.

  • GlobeNewswire2 months ago

    Khiron Life Sciences Completes Acquisition of ILANS

    TORONTO, Dec. 13, 2018 -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with.

  • CNW Group2 months ago

    Khiron Life Sciences Receives Endorsement from Prominent Colombian Medical Association for the Study of Pain

    TORONTO , Dec. 11, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce it has signed an endorsement agreement with the highly respected and influential Colombian Association for the Study of Pain (ACED). In endorsing Khiron's patient-focused approach to medical cannabis research and product development, ACED has committed to partnering with the Company on a schedule of patient and physician education programs, modules and events.

  • CNW Group3 months ago

    Khiron Life Sciences Enters Mexican Cannabis Market With The Launch of Its First Nutraceutical Product Line

    TORONTO , Dec. 3, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia , announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has received approval from Mexico's Federal Commission for the Protection against Sanitary Risk  (COFEPRIS) to import and commercialize three products of the Company's Nutraceutical Line. The commencement of sales in Mexico is subject to prior TSX Venture Exchange ("TSXV") approval.

  • GlobeNewswire3 months ago

    Khiron Life Sciences Reports Third Quarter Fiscal 2018 Financial Results

    Khiron Life Sciences Corp. (“Khiron” or the “Company”) (KHRN.V) (KHRNF) (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today its financial results for the third quarter ended September 30, 2018. Appointed Mr. Vicente Fox to the Khiron Board of Directors. Mr. Fox is the former CEO of Coca Cola Mexico, former President of Mexico and a significant advocate for the legalization of cannabis in Mexico.

  • GlobeNewswire3 months ago

    Breaking News: Passage of 2018 Farm Bill could open cannabis cosmetics industry to players like Aurora Cannabis, Khiron Life Sciences, American Premium Water Corp, and LVMH’s Sephora

    The 2018 Farm Bill is “very close to passing” according to Collin Peterson, Rep D-Minnesota, and added with the recent legalization in Canada, there has been a focus on companies in the recreational and medical cannabis sector. With the growing spotlight on CBD oil use for medical purposes, it may be surprising to learn that CBD is being used in beauty products as well. Scientists are discovering that CBD oil has many other uses, other than for medical purposes, and when it comes to beauty products it may be the most natural product you can use.